Volume 28, Number 9—September 2022
Research
Rapid Adaptation of Established High-Throughput Molecular Testing Infrastructure for Monkeypox Virus Detection
Table 1
Primer and probe sequences for a dual-target MPXV assay rapidly adapted from established high-throughput SARS-CoV-2 molecular testing infrastructure*
Oligotype | Oligo name | Sequence, 5′ → 3′ | Final concentration, nM |
---|---|---|---|
Primers | NVAR fwd | TCA ACT GAA AAG GCC ATC TAT (2'OMe-G)A | 400 |
NVAR rev | GAG TAT AGA GCA CTA TTT CTA AAT CC(2'OMe-C) A | 400 | |
MPOX fwd | ACG TGT TAA ACA ATG GGT GA(2'OMe-U) G | 400 | |
MPOX rev |
AAC ATT TCC ATG AAT CGT AGT (2'OMe-C)C |
400 |
|
Probes | NVAR P-YAK | YakYellow-CCA TGC AAT (BHQ1)ATA CGT ACA AGA TAG TAG CCA AC-BHQ1 | 75 |
MPOX P-FAM | FAM-TGA ATG AAT (BHQ1)GCG ATA CTG TAT GTG TGG G-BHQ1 | 75 |
*Sequences are derived from previously published NVAR assay by Li et al. (9) and MPXV assay by Shchelkunov et al. (10) and adapted for the cobas omni Utility Channel (Roche Diagnostics, https://diagnostics.roche.com). Oligos were custom made by Ella Biotech GmbH (https://www.ellabiotech.com). Indicated final concentration refers to the final oligo concentrations within the reaction mix. 2′O-methyl-RNA bases are indicated as OMe-X. Internal abasic quenchers are indicated as (BHQ1). NVAR, nonvariola orthopoxvirus; MPXV, monkeypox virus.
References
- World Health Organization. Disease outbreak news: multi-country monkeypox outbreak in non-endemic countries 29 May 2022 [cited 2022 Jun 7]. https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON388
- Antinori A, Mazzotta V, Vita S, Carletti F, Tacconi D, Lapini LE, et al.; INMI Monkeypox Group. Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022. Euro Surveill. 2022;27:
2200421 . DOIPubMedGoogle Scholar - Vivancos R, Anderson C, Blomquist P, Balasegaram S, Bell A, Bishop L, et al.; UKHSA Monkeypox Incident Management team; Monkeypox Incident Management Team. Community transmission of monkeypox in the United Kingdom, April to May 2022. Euro Surveill. 2022;27:
2200422 . DOIPubMedGoogle Scholar - Perez Duque M, Ribeiro S, Martins JV, Casaca P, Leite PP, Tavares M, et al. Ongoing monkeypox virus outbreak, Portugal, 29 April to 23 May 2022. Euro Surveill. 2022;27:
2200424 . DOIPubMedGoogle Scholar - Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR, et al. The changing epidemiology of human monkeypox-A potential threat? A systematic review. PLoS Negl Trop Dis. 2022;16:
e0010141 . DOIPubMedGoogle Scholar - Reed KD, Melski JW, Graham MB, Regnery RL, Sotir MJ, Wegner MV, et al. The detection of monkeypox in humans in the Western Hemisphere. N Engl J Med. 2004;350:342–50. DOIPubMedGoogle Scholar
- Adalja A, Inglesby T. A novel international monkeypox outbreak. Ann Intern Med. 2022 May 24 [Epub ahead of print].
- Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25:25. DOIPubMedGoogle Scholar
- Pfefferle S, Reucher S, Nörz D, Lütgehetmann M. Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system. Euro Surveill. 2020;25:
2000152 . DOIPubMedGoogle Scholar - Müller G, Meyer A, Gras F, Emmerich P, Kolakowski T, Esposito JJ. Monkeypox virus in liver and spleen of child in Gabon. Lancet. 1988;1:769–70. DOIPubMedGoogle Scholar
- Poljak M, Korva M, Knap Gašper N, Fujs Komloš K, Sagadin M, Uršič T, et al. Clinical evaluation of the cobas SARS-CoV-2 test and a diagnostic platform switch during 48 hours in the midst of the COVID-19 pandemic. J Clin Microbiol. 2020;58:e00599–20. DOIPubMedGoogle Scholar
- Adler H, Gould S, Hine P, Snell LB, Wong W, Houlihan CF, et al. NHS England High Consequence Infectious Diseases (Airborne) Network. Clinical features and management of human monkeypox: a retrospective observational study in the UK. Lancet Infect Dis. 2022 May 24 [Epub ahead of print].